Molecular Classification of Multiple Myeloma: A Distinct Transcriptional Profile Characterizes Patients Expressing <i>CCND1</i> and Negative for 14q32 Translocations

Abstract

Our data contribute to the understanding of the molecular and biologic features of distinct MM subtypes. The identification of a distinctive gene expression pattern in TC2 patients may improve risk stratification and indicate novel therapeutic targets.